급성호흡기감염 환자의 표시과목별 항생제 처방특성 -국민건강보험 빅데이터를 활용하여-
Prescription Characteristics of Antibiotics for Clinical Subjects of Acute Respiratory Infection Outpatients -Using National Health Insurance Big Data-
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study analyzed the prescription antibiotics characteristics of Acute respiratory infection outpatients. It provides a basis for establishing the correct evaluation project on appropriate prescribing indicators. Methods: The research data were collected from the National Health Insurance Corporation's 2014 sample cohort for Internal Medicine, Pediatrics, Otorhinolaryngology, Family Medicine and General practitioner clinics classification of diseases codes J00-J06, J20-J22, J40 outpatients. Results: The antibiotic prescription rate on the evaluation project for appropriate prescribing indicators of Health Insurance Review & Assessment Service was 43.54%, whereas in this study it was about 10% higher because the analysis targeted the entire acute respiratory infection diagnosis. Conclusions: There is a need to identify the correct antibiotic prescription by expanding the current assessment standard. Such standard must include acute lower respiratory infections and minor diagnosis because current evaluation projects on appropriate prescribing indicators targets only the major diagnosis of acute upper respiratory infection.
Abstract
Objectives: This study analyzed the prescription antibiotics characteristics of Acute respiratory infection outpatients. It provides a basis for establishing the correct evaluation project on appropriate prescribing indicators. Methods: The research data were collected from the National Health Insurance Corporation's 2014 sample cohort for Internal Medicine, Pediatrics, Otorhinolaryngology, Family Medicine and General practitioner clinics classification of diseases codes J00-J06, J20-J22, J40 outpatients. Results: The antibiotic prescription rate on the evaluation project for appropriate prescribing indicators of Health Insurance Review & Assessment Service was 43.54%, whereas in this study it was about 10% higher because the analysis targeted the entire acute respiratory infection diagnosis. Conclusions: There is a need to identify the correct antibiotic prescription by expanding the current assessment standard. Such standard must include acute lower respiratory infections and minor diagnosis because current evaluation projects on appropriate prescribing indicators targets only the major diagnosis of acute upper respiratory infection.
참고문헌 (19)
- J.A.I. Weigl, "Ten Years Experience with Year-Round Active Surveillance of Up to 19 Respiratory Pathogens in Children", Eur J Pediatr, 166(1), pp.957~966 (2007)
- Pewvalence of Respiratory Viruses in Acute Respiratory Infections in Korea, 2007, "KCDC", KCDC, 1~8 (2008)
- Acute Infectious Agents Laboratory Surveillance Report(ARI Net), "NIH", KCDC, 1~10 (2013)
- Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report 2019, "Health Insurance Review & Assessment Service", HIRA, 1~79, pp.HIRA Assessment 4 (2019)
- 김지애, "건강보험청구자료를 이용한 외래 급성 호흡기계 질환 방문과 항생제 처방률 변화 분석", 한국임상약학회지, 27(3), pp.186~194 (2017), 한국임상약학회[DOI]
- 김예지, "소아 호흡기감염 외래환자에 대한 항생제 처방양상", 보건행정학회지, 25(4), pp.323~333 (2015), 한국보건행정학회
- 최원정, "급성상기도감염 환자의 항생제 처방에 영향을 주는 요인", 보건행정학회지, 25(4), pp.256~263 (2015), 한국보건행정학회
- 공미진, "1차 의료기관의 급성 상기도 감염 질환자 의약품 처방특성 - 가정의학과, 내과, 소아청소년과, 이비인후과, 일반의 중심으로 -", 보건의료산업학회지, 11(3), pp.37~49 (2017), 보건의료산업학회
- Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report(The first half year), "Health Insurance Review & Assessment Service", HIRA, 1~54, pp.HIRA Assessment 4 (2014)
- Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report(The second half year), "Health Insurance Review & Assessment Service", HIRA, 1~70, pp.HIRA Assessment 4 (2014)
- 김수경, "급성상기도감염 항생제 처방률 공개 효과 분석", 한국임상약학회지, 20(3), pp.242~247 (2010), 한국임상약학회
- Evaluation Project on Appropriate Prescribing Indicators Assessment Result Report(The second half year), "Health Insurance Review & Assessment Service", HIRA, 1~66, pp.HIRA Assessment 4 (2011)
- National Action Plan on Antimicrobial Resistance(2016~2020), "MOHW", Ministry of Health & Welfare, 1~36 (2016)
- 강혜경, "급성 상기도 감염에서 항생제 처방개선에 관한 연구", 한국임상약학회지, 22(1), pp.47~54 (2012), 한국임상약학회
- 김성철, "울산 지역 소아청소년과 및 이비인후과에서의 항생제 처방 형태", 한국임상약학회지, 20(2), pp.145~150 (2010), 한국임상약학회
- 채수미, "외래 급성 상기도 감염에서의 항생제 사용량 및 약품비 추계", 약 학 회 지, 57(3), pp.199~204 (2013), 대한약학회
- 허재균, "소아의 상기도 감염증", 대한의사협회지, 53(1), pp.5~9 (2010), 대한의사협회